CGP 51901
Alternative Names: AL 901; Antiallergy MAbLatest Information Update: 14 Mar 2008
At a glance
- Originator Tanox
- Class Antiallergics; Monoclonal antibodies
- Mechanism of Action Immunoglobulin inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Seasonal allergic rhinitis
Most Recent Events
- 22 Jun 1999 Tanox Biosystems is now called Tanox
- 19 Oct 1998 Suspended-I for Seasonal allergic rhinitis in United Kingdom (Unknown route)
- 19 Oct 1998 Suspended-II for Asthma in United Kingdom (Unknown route)